Remote communities of healthcare professionals are enabling DCTs
Hawthorne Effect’s Hero network is enabling continuous data capture in remote and hard to reach communities.
ByClinical Trials Arena
pHOXBIO eyes UK study of preventive Covid-19 nasal spray by year’s end
The nasal spray is designed to offer hours of protection from a SARS-CoV-2 infection.
By
Uneven Covid-19 vaccine efficacy in blood cancers mean masks to stay
A quarter of haematological cancer patients do not mount an effective immune response after Covid-19 vaccination.
By
Tools4Patient Q&A: predicting the placebo response to cut trial failure rates
Placebell is a tool that helps to remove the risk of the placebo phenomenon in clinical trials, reducing the risk…
By
Delivering gene therapy directly to the brain for AADC deficiency
PTC Therapeutics’ gene therapy delivered directly to the brain is yielding life-changing results in children with AADC deficiency.
By
Rare Diseases 2021: maintaining the human element in decentralised trials
AGTC’s director of patient enrollment discusses the importance of the human touch in decentralised rare disease clinical trials.
By
Rare Diseases 2021: running rare disease trials post-Covid
At this week’s Clinical Trials in Rare Diseases Conference 2021, experts shared insights on running effective rare disease trials.
By
Hunting the holy grail: the marred history of HIV vaccine trials
With the recent news that Moderna is set to start human trials of its mRNA HIV vaccine, CTA charts the…
By